Remedy Entertainment has reported a substantial surge in third-quarter revenue, with earnings reaching €39.6 million (approximately $44.3 million), a 226% increase attributed to the successful launch of Control Resonant. The studio's CEO, Jean-Charles Gaudechon, described the performance as a "defining milestone" for the company.
Financially, Remedy posted an operating profit of €0.6 million (about $670,794) for the quarter, a significant improvement from the €16.4 million (approximately $18.3 million) loss incurred in the same period last year. Control Resonant has achieved over one million unit sales, making it Remedy's fastest-selling title to date. Sales have been particularly strong in the United States, with the game also performing well in the UK. Notably, half of the players who purchased Control Resonant were new to the franchise.
"Reaching new players was a key goal for this game, and these early results indicate a growing audience for the franchise and for Remedy," Gaudechon stated, indicating the developer's intention to further expand the game's reach. The success of Control Resonant is expected to provide financial stability for Remedy as it progresses on other projects, including the remake of Max Payne 1 & 2. The game is also currently on 2.4 million wishlists, signaling strong potential for future sales.
Gaudechon expressed confidence in the game's long-term sales prospects, citing "excellent player reviews, penetration in all our target markets and a substantial outstanding wishlist base." He added that these factors, combined with organic visibility and targeted marketing, provide a solid foundation.
In other studio news, Gaudechon mentioned that FBC: Firebreak is being played primarily through subscription services like Game Pass and PlayStation Plus, resulting in lower revenue in its second year. The Alan Wake franchise experienced a quieter quarter, though development costs for Alan Wake 2 were fully depreciated during the third quarter.